| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |